Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Sep 19, 2025 · Antiphospholipid (AN-te-fos-fo-LIP-id) syndrome is a condition in which the immune system mistakenly makes antibodies that attack tissues in the body. These antibodies can cause …

6 days ago · Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to …

Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the …

5 days ago · A detailed overview of Apellis Pharmaceuticals, Inc. (APLS) stock, including real-time price, chart, key statistics, news, and more.

Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

1 day ago · Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to …

Dec 16, 2025 · See the latest Apellis Pharmaceuticals Inc stock price (APLS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Dec 18, 2025 · APLS's current price target is $33.06. Learn why top analysts are making this stock forecast for Apellis Pharmaceuticals at MarketBeat.

3 days ago · Get the latest Apellis Pharmaceuticals, Inc APLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.